
    
      Double-blind, randomized, multi-center, placebo-controlled, comparative exploratory phase
      II-finding trial.The study will be conducted with four treatment groups in the form of a
      parallel-group comparison and will serve to compare oral treatment with either 500 mg/d, 1000
      mg/d or 1500 mg/d norursodeoxycholic acid capsules vs. Placebo capsules for the treatment of
      PSC.
    
  